Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
University of Rochester NCORP Research Base
Status
Completed
NCT ID
NCT03186638
This randomized phase II trial studies how well low-dose ibuprofen in improving cognitive impairment in patients with cancer. Anti-inflammatory agents, such as ibuprofen, may slow the decline of cognitive processes and diseases involving the brain.
Intervention
Ibuprofen, Placebo, Questionnaire Administration
Condition
Cognitive Impairment, Malignant Neoplasm
Investigators
Michelle C Janelsins